Literature DB >> 24101055

Prostate cancer and the hypofractionation hypothesis.

W Robert Lee1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24101055     DOI： 10.1200/JCO.2013.52.4942

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Is there any benefit from hypofractionation in external-beam irradiation for prostate cancer?

Authors:  Mark J Brenner; Irving D Kaplan
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

2.  A feasibility dosimetric study on prostate cancer : are we ready for a multicenter clinical trial on SBRT?

Authors:  Carmelo Marino; Elena Villaggi; Giulia Maggi; Marco Esposito; Lidia Strigari; Elisa Bonanno; Giusi R Borzì; Claudia Carbonini; Rita Consorti; David Fedele; Christian Fiandra; Isidora Ielo; Tiziana Malatesta; Maria Rosa Malisan; Anna Martinotti; Renzo Moretti; Barbara Nardiello; Caterina Oliviero; Stefania Clemente; Pietro Mancosu
Journal:  Strahlenther Onkol       Date:  2015-03-08       Impact factor: 3.621

Review 3.  Image-guided focal therapy for prostate cancer.

Authors:  Sandeep Sankineni; Bradford J Wood; Soroush Rais-Bahrami; Annerleim Walton Diaz; Anthony N Hoang; Peter A Pinto; Peter L Choyke; Barış Türkbey
Journal:  Diagn Interv Radiol       Date:  2014-11       Impact factor: 2.630

4.  Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

Authors:  W Robert Lee; James J Dignam; Mahul B Amin; Deborah W Bruner; Daniel Low; Gregory P Swanson; Amit B Shah; David P D'Souza; Jeff M Michalski; Ian S Dayes; Samantha A Seaward; William A Hall; Paul L Nguyen; Thomas M Pisansky; Sergio L Faria; Yuhchyau Chen; Bridget F Koontz; Rebecca Paulus; Howard M Sandler
Journal:  J Clin Oncol       Date:  2016-04-04       Impact factor: 44.544

5.  Reducing the cost of proton radiation therapy: the feasibility of a streamlined treatment technique for prostate cancer.

Authors:  Wayne D Newhauser; Rui Zhang; Timothy G Jones; Annelise Giebeler; Phillip J Taddei; Robert D Stewart; Andrew Lee; Oleg Vassiliev
Journal:  Cancers (Basel)       Date:  2015-04-24       Impact factor: 6.639

6.  Enhanced DNA Damages of Human Prostate Cancer Cells Induced by Radiofrequency Capacitive Hyperthermia Pre- and Post X-rays: 6 MV versus 15 MV.

Authors:  Seied Rabi Mahdavi; Azam Janati Esfahani; Mohammad Bagher Shiran; Samideh Khoei; Nader Estiri
Journal:  Cell J       Date:  2017-05-17       Impact factor: 2.479

7.  Delivery of Radiation at the Lowest Dose Rate by a Modern Linear Accelerator is Most Effective in Inhibiting Prostate Cancer Growth.

Authors:  Keren Tazat; Oleg Reshetnyak; Natan Shtraus; Ifat Sayag; Nicola J Mabjeesh; Sharon Amir
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 8.  Proton Therapy for Prostate Cancer: Challenges and Opportunities.

Authors:  Darren M C Poon; Stephen Wu; Leon Ho; Kin Yin Cheung; Ben Yu
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

9.  Acute toxicity and patient-reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer.

Authors:  Takashi Iizumi; Hitoshi Ishikawa; Yuta Sekino; Keiichi Tanaka; Daichi Takizawa; Hirokazu Makishima; Haruko Numajiri; Masashi Mizumoto; Kei Nakai; Toshiyuki Okumura; Hideyuki Sakurai
Journal:  J Med Radiat Sci       Date:  2021-10-19

10.  Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.

Authors:  Karen E Hoffman; K Ranh Voong; Lawrence B Levy; Pamela K Allen; Seungtaek Choi; Pamela J Schlembach; Andrew K Lee; Sean E McGuire; Quynh Nguyen; Thomas J Pugh; Steven J Frank; Rajat J Kudchadker; Weiliang Du; Deborah A Kuban
Journal:  J Clin Oncol       Date:  2018-08-14       Impact factor: 50.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.